Nanotoxicology: Nano Toxicity in Humans

Research Article | DOI: https://doi.org/10.31579/2693-7247/059

Nanotoxicology: Nano Toxicity in Humans

  • Sadique Hussain 1

School of Pharmaceutical Sciences, Jaipur National University, Jagatpura (302017), Jaipur, Rajasthan, India.

*Corresponding Author: Sadique Hussain, School of Pharmaceutical Sciences, Jaipur National University, Jagatpura (302017), Jaipur, Rajasthan, India

Citation: Sadique Hussain, (2022) Nanotoxicology: Nano Toxicity In Humans. J. Pharmaceutics and Pharmacology Research. 5(1); DOI: 10.31579/2693-7247/059

Copyright: © 2022 Sadique Hussain, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 23 November 2021 | Accepted: 15 December 2021 | Published: 04 January 2022

Keywords: nanotoxicology; physicochemical; biomedical use

Abstract

Nanoparticles (NPs) have attracted a lot of attention in the fields of electronics, biology, and astronautics because of their unique physicochemical and electrical characteristics. NPs are materials with at least one dimension of fewer than 100 nanometres that are commercially manufactured (Bahadar et al., 2016; Vishwakarma et al., 2010). In the medical field, drugs, proteins, DNA, and monoclonal antibodies are all being delivered via NPs(Hussain et al., 2021). 

Introduction

Although the name "nanotoxicology" may cause concern among the general public, it is a relatively young discipline of toxicology that tackles the information gap about toxicity caused by NPs. This new area of toxicology, according to Priyanka et al., presents techniques to access the toxicity generated by nanoparticles. For toxicity evaluation in people and the environment, this section comprises a fundamental understanding of the physicochemical impacts of NPs and their routes of exposure/uptake processes (Ganguly et al., 2018). The overall purpose of nanotoxicology is to define criteria for making safe nanoparticles. This necessitates a thorough, systemic approach to examining NP toxicity and its impact on cells, tissues, organs, and the entire organism(Donaldson et al., n.d.). The physical and chemical features of NPs, such as size, shape, specific surface area, surface charge, catalytic activity, and the presence or absence of a shell and active groups on the surface, all influence their toxicity(Sukhanova et al., 2018). Because of their small dimensions and unique features, NPs are frequently exploited as nanomedicine and drug nanocarriers. Their toxicity towards normal, healthy human cells, tissues, and organs might be due to their size, shape, surface functional groups, and dose-dependent characteristics. Numerous researchers have discovered that chemically synthesized NPs are more harmful to human cells than biosynthesized NPs with biocompatible surface functional groups due to the presence of synthetic chemicals as surface functional and capping agents. On the other hand, certain biosynthesized NPs can be harmful when they react with cells and disintegrate into simpler forms or accumulate (Egbuna et al., 2021). Nanotoxicology has just recently arisen, years after NPs first boom when many nanomaterials had already been used in a variety of industrial processes and products(Elsaesser & Howard, 2012).

NPs' physiochemical qualities have an impact on how they interact with cells and, as a result, on their total potential toxicity. Understanding these qualities can lead to the creation of NPs that are safer. Recent research has begun to pinpoint the characteristics that make certain NPs more dangerous than others. In theory, particle size might have a role in cytotoxicity. Smaller NPs have a bigger specific surface area (SSA) than larger NPs with the same mass, and hence a more accessible surface area to interact with biological components such nucleic acids, proteins, fatty acids, and carbohydrates. Because of its tiny size, it is more likely to infiltrate cells and cause harm. Toxicity was discovered to be a function of both size and SSA in certain NPs. When evaluating the number of reactive oxygen species (ROS) generation per surface area within a given size range, the size of anatase TiO2 was demonstrated to correlate with ROS production(Huang et al., 2017). In summary, the following are the most typical pathways of NPs cytotoxicity (Sukhanova et al., 2018):

1. NPs can induce oxidation by forming reactive oxygen species (ROS) and other free radicals;

2. NPs can perforate cell membranes, causing harm.

3. NPs disrupt intracellular transport and cell division by damaging cytoskeleton components.

4. NPs disrupt transcription and damage DNA, speeding up the mutagenesis process;

5. NPs harm mitochondria and disrupt their metabolism, resulting in an energy imbalance in the cell;

6. NPs prevent the development of lysosomes, impairing autophagy and macromolecule breakdown as well as causing apoptosis;

7. NPs alter the structure of membrane proteins and disrupt the movement of substances into and out of cells, including intercellular transport; 

8. NPs trigger the production of inflammatory mediators by disrupting normal cell, tissue, and organ metabolism;

NPs’ structure and physicochemical characteristics must be extensively defined and understood to accurately assess NPs'safety. To develop particular nanoparticle structure-activity/toxicity functional connections, reported harmful effects can be better linked to certain NPs features. Because NPs structural features influence toxicity, evaluating the safety of NPs with substantial changes in physicochemical qualities, as observed in natural and accidental nanoparticles, is considerably more difficult(Yang et al., 2021).

 

Table 1: Examples of nanoparticle toxicity in human subjects

 

Conclusion

Because of their physicochemical and behavioral distinctiveness, nanoparticles have found extensive biomedical use, yet worries about their harmful consequences in the biological system are now attracting the attention of the worldwide health community. This involves the research and comprehension of the impacts based on the cellular and molecular processes by which they produce these effects. As a result, drawing broad generalizations about nanoparticle toxicity is difficult since nanotoxicity is based on complicated interactions between many physicochemical features and the associated biological context. The public is concerned about widespread human exposure to nanoparticles. As a result, improved techniques for assessing the safety of nanoparticles are required. The current state of knowledge on the impacts of nanomaterials on humans is quite limited.

Conflicts Of Interest

The authors declare no conflicts of interest.

Funding

None

References

Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.

img

Dr Elena Popa

It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.

img

Dr Nikolaos Andreas Chrysanthakopoulos

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee

img

Robert W McGee

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D

img

Aibing Rao

I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.

img

Kashani Mehdi

Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,

img

Alla Konstantinovna Politova